TY - JOUR
T1 - Safe prescription recommendations for non steroidal anti-inflammatory drugs: Consensus document ellaborated by nominated experts of three scientific associations (SER-SEC-AEG)
AU - Lanas, Angel
AU - Benito, Pere
AU - Alonso, Joaquín
AU - Hernández-Cruz, Blanca
AU - Barón-Esquivias, Gonzalo
AU - Perez-Aísa, Ángeles
AU - Calvet, Xavier
AU - García-Llorente, José Francisco
AU - Gobbo, Milena
AU - Gonzalez-Juanatey, José R.
PY - 2014/1/1
Y1 - 2014/1/1
N2 - This article outlines key recommendations for the appropriate prescription of non steroidal anti-inflammatory drugs to patients with different musculoskeletal problems. These recommendations are based on current scientific evidence, and takes into consideration gastrointestinal and cardiovascular safety issues. The recommendations have been agreed on by experts from three scientific societies (Spanish Society of Rheumatology [SER], Spanish Association of Gastroenterology [AEG] and Spanish Society of Cardiology [SEC]), following a two-round Delphi methodology. Areas that have been taken into account encompass: efficiency, cardiovascular risk, gastrointestinal risk, liver risk, renal risk, inflammatory bowel disease, anemia, post-operative pain, and prevention strategies. We propose a patient management algorithm that summarizes the main aspects of the recommendations. © 2013 Elsevier España, S.L. and AEEH y AEG.
AB - This article outlines key recommendations for the appropriate prescription of non steroidal anti-inflammatory drugs to patients with different musculoskeletal problems. These recommendations are based on current scientific evidence, and takes into consideration gastrointestinal and cardiovascular safety issues. The recommendations have been agreed on by experts from three scientific societies (Spanish Society of Rheumatology [SER], Spanish Association of Gastroenterology [AEG] and Spanish Society of Cardiology [SEC]), following a two-round Delphi methodology. Areas that have been taken into account encompass: efficiency, cardiovascular risk, gastrointestinal risk, liver risk, renal risk, inflammatory bowel disease, anemia, post-operative pain, and prevention strategies. We propose a patient management algorithm that summarizes the main aspects of the recommendations. © 2013 Elsevier España, S.L. and AEEH y AEG.
KW - Adverse event
KW - Cardiovascular
KW - Gastrointestinal hemorrhage
KW - Non steroidal anti-inflammatory drugs
KW - Peptic ulcer
U2 - 10.1016/j.gastrohep.2013.11.014
DO - 10.1016/j.gastrohep.2013.11.014
M3 - Article
SN - 1699-258X
VL - 10
SP - 68
EP - 84
JO - Reumatologia Clinica
JF - Reumatologia Clinica
IS - 2
ER -